{"id":"https://openalex.org/W2051983014","doi":"https://doi.org/10.1111/bjh.13248","title":"Post\u2010transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high\u2010risk acute myeloid leukaemia","display_name":"Post\u2010transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high\u2010risk acute myeloid leukaemia","publication_year":2014,"publication_date":"2014-12-17","ids":{"openalex":"https://openalex.org/W2051983014","doi":"https://doi.org/10.1111/bjh.13248","mag":"2051983014","pmid":"https://pubmed.ncbi.nlm.nih.gov/25522128"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.13248","doi":"https://doi.org/10.1111/bjh.13248","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.13248","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13248","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13248","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032874540","display_name":"Gaku Oshikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Gaku Oshikawa","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072446428","display_name":"Kazuhiko Kakihana","orcid":"https://orcid.org/0000-0001-5062-5795","observed_orcids":["https://orcid.org/0000-0001-5062-5795"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiko Kakihana","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Makoto Saito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Saito","raw_affiliation_strings":["Divisions of Clinical Research Support, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Clinical Research Support, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101879795","display_name":"Jun Aoki","orcid":"https://orcid.org/0000-0002-3412-0073","observed_orcids":["https://orcid.org/0000-0002-3412-0073"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun Aoki","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075476949","display_name":"Yuho Najima","orcid":"https://orcid.org/0000-0001-8910-0021","observed_orcids":["https://orcid.org/0000-0001-8910-0021"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuho Najima","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042854652","display_name":"Takeshi Kobayashi","orcid":"https://orcid.org/0000-0002-5532-207X","observed_orcids":["https://orcid.org/0000-0002-5532-207X"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Kobayashi","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033486602","display_name":"Noriko Doki","orcid":"https://orcid.org/0000-0002-8661-3179","observed_orcids":["https://orcid.org/0000-0002-8661-3179"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Doki","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074811645","display_name":"Hisashi Sakamaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisashi Sakamaki","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110071521","display_name":"Kazuteru Ohashi","orcid":"https://orcid.org/0000-0002-5128-0693","observed_orcids":["https://orcid.org/0000-0002-5128-0693"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuteru Ohashi","raw_affiliation_strings":["Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I3020605285"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3020605285"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":2.3335,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.89218565,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"169","issue":"5","first_page":"756","last_page":"759"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6352999806404114,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6352999806404114,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.3564000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9350000023841858},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7559999823570251},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/gemtuzumab-ozogamicin","display_name":"gemtuzumab ozogamicin","score":1.0},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.4830000102519989},{"id":"https://openalex.org/keywords/graft-versus-leukemia-effect","display_name":"graft-versus-leukemia effect","score":0.9589999914169312},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.949999988079071},{"id":"https://openalex.org/keywords/high-risk-aml","display_name":"high-risk AML","score":0.7020000219345093},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C2778623314","wikidata":"https://www.wikidata.org/wiki/Q412685","display_name":"Gemtuzumab ozogamicin","level":5,"score":0.9800474047660828},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7973967790603638},{"id":"https://openalex.org/C2993296363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukaemia","level":2,"score":0.7476413249969482},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.740760862827301},{"id":"https://openalex.org/C2778245361","wikidata":"https://www.wikidata.org/wiki/Q409744","display_name":"Calicheamicin","level":3,"score":0.5933824181556702},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.5282368063926697},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.444536030292511},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44367244839668274},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.3709309995174408},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.28687793016433716},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27678239345550537},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.18945783376693726},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.13895612955093384},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000079982","descriptor_name":"Gemtuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060046","descriptor_name":"Maintenance Chemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjh.13248","doi":"https://doi.org/10.1111/bjh.13248","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.13248","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13248","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:25522128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25522128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1111/bjh.13248","doi":"https://doi.org/10.1111/bjh.13248","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.13248","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13248","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2051983014.pdf","grobid_xml":"https://content.openalex.org/works/W2051983014.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W90521908","https://openalex.org/W1796660362","https://openalex.org/W2013194808","https://openalex.org/W2051877520","https://openalex.org/W2066076021","https://openalex.org/W2074326274","https://openalex.org/W2099261151","https://openalex.org/W2115373063","https://openalex.org/W2150744959","https://openalex.org/W2168608024","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2809925189","https://openalex.org/W2089651698","https://openalex.org/W3025827814","https://openalex.org/W1976648625","https://openalex.org/W2244507987","https://openalex.org/W1573788508","https://openalex.org/W2080619461","https://openalex.org/W3005849948","https://openalex.org/W2781565767","https://openalex.org/W4235505556"],"abstract_inverted_index":{"Relapse":[0],"is":[1,358,1033,1116],"a":[2,63,67,118,128,140,161,504,550,661,933,952,957,1042],"major":[3],"cause":[4],"of":[5,88,137,164,208,288,292,330,349,355,385,407,414,426,464,498,507,527,556,561,563,712,753,817,825,936,960,996,1039,1124],"treatment":[6,209,218,415,427,975,992],"failure":[7],"in":[8,70,157,360,419,431,449,459,467,473,480,596,618,658,670,688,692,874,879,920,977,1013,1026,1055],"allogeneic":[9],"haematopoietic":[10],"stem":[11],"cell":[12],"transplantation":[13],"(allo-HSCT)":[14],"for":[15,46,122,951,1001,1077,1119,1145],"acute":[16,522],"myeloid":[17],"leukaemia":[18],"(AML),":[19],"and":[20,82,113,135,152,219,305,327,375,400,455,477,484,500,558,582,699,773,833,887,947,994,1071,1086,1093,1100],"the":[21,28,85,133,286,289,347,382,404,423,525,541,611,615,736,781,813,823,848,865,900,913,925,990,1014,1037,1051,1064,1089,1096,1103,1120,1130,1142,1146],"clinical":[22,353,849],"outcomes":[23],"are":[24,998,1047],"very":[25,1048],"poor.":[26],"Recently,":[27],"MD":[29],"Anderson":[30],"Cancer":[31,1070],"Centre":[32,1074],"group":[33,876,902],"reported":[34,60],"promising":[35],"data":[36],"on":[37,179,188,827],"maintenance":[38,141,637,1005,1044],"therapy":[39,110,142,638,1006],"with":[40,111,147,241,660,812,839,899,1007,1028],"low-dose":[41],"azacitidine":[42],"(AZA)":[43],"after":[44,143,202,381,403,553,624,646,723,771,801],"allo-HSCT":[45,316,326,374,800],"AML":[47,240],"or":[48,197,1122],"myelodysplastic":[49],"syndrome":[50],"(MDS)":[51],"(de":[52],"Lima":[53],"et":[54,75,79,93,97,105,630,634,784],"al,":[55,76,80,94,98,106,631,635,785],"2010).":[56],"AZA":[57,112,172],"has":[58],"been":[59],"to":[61,83,116,131,443,447,515,573,614,705,735,741,1010,1035,1050,1062,1141],"augment":[62],"graft-versus-leukaemia":[64],"effect":[65,87],"without":[66,317,970],"concomitant":[68],"increase":[69,84],"graft-versus-host":[71],"disease":[72],"(GVHD)":[73],"(Choi":[74],"2010;":[77],"Sanchez-Abarca":[78],"2010)":[81],"anti-leukaemic":[86],"gemtuzumab":[89],"ozogamicin":[90],"(GO)":[91],"(Pinto":[92],"1984;":[95],"Linenberger":[96],"2001;":[99],"Balaian":[100],"&":[101],"Ball,":[102],"2006;":[103],"Nand":[104],"2013).":[107],"Therefore,":[108,726],"combination":[109],"GO":[114,184,818,1092],"seems":[115,1009],"be":[117,640,654,810,918,930,982,1011,1139],"theoretically":[119],"valid":[120],"strategy":[121],"improving":[123],"therapeutic":[124],"response.":[125],"We":[126,1046],"conducted":[127],"pilot":[129],"study":[130,159,1032],"evaluate":[132,822],"safety":[134],"efficacy":[136,1038],"AZA-GO":[138,191,293,331,408,493,528,593,652,698,804,826,869,875,961,997,1008,1022,1040],"as":[139,198,200,642,644,1041],"allo-HSCT.":[144,647],"Ten":[145],"patients":[146,313,341,388,396,433,441,451,489,518,576,659,791,798,866,937,944,965,979,1027,1052],"high-risk":[148,1029],"AML,":[149],"eight":[150],"males":[151],"two":[153,481,943],"females,":[154],"were":[155,342,501,591,732,837,844],"enrolled":[156],"this":[158,764,857,1056],"at":[160,173,185,285,346,503,851,881,892,1067],"median":[162,281,323,364,412,424,505],"age":[163],"49\u00b75":[165],"years":[166],"(range:":[167,335,370,378,510],"17\u201365":[168],"years)":[169],"(Table":[170,338,529,586,715,854],"1).":[171,339,410,487,530,587,716,963],"30":[174],"mg/m2":[175,187],"was":[176,192,211,332,367,417,429,594,602,775],"administered":[177,656],"intravenously":[178],"days":[180],"1\u20137,":[181],"followed":[182],"by":[183,745,1129],"3":[186,399,430,454],"day":[189],"8.":[190],"repeated":[193,983],"every":[194,494,984],"4":[195,212,233,248,277,495,579,985],"weeks":[196,496,552],"soon":[199,643],"possible":[201,645],"haematological":[203,580,589,724],"recovery.":[204,725],"The":[205,280,322,351,363,411,974,1058,1105,1114],"maximum":[206],"number":[207,413,425,935],"cycles":[210,416,428],"(for":[213],"detailed":[214],"information":[215,1127],"regarding":[216],"eligibility,":[217],"transplant":[220],"procedure,":[221],"please":[222],"see":[223],"'Supporting":[224],"information').":[225],"20":[226],"F":[227,246],"31":[228],"M":[229,237,252,254,256,262,269,275],"PIF":[230,263],"MLL-AF6":[231],"Flu-BU-ATG-":[232],"Gy":[234,249,259,272,278],"TBI":[235,250,260,273,279],"59":[236],"Refractory":[238],"relapse":[239,437,448,623,802],"MRC":[242],"Monosomal":[243],"karyotype":[244],"44":[245,255],"Flu-Mel-AraC-":[247],"65":[251],"57":[253],"Flu-AraC-CY-ATG-":[257,270],"8":[258,271,483],"62":[261],"Leukaemic":[264],"evolution":[265],"from":[266,373,756,847],"CMML":[267],"55":[268],"17":[274],"Flu-Mel-AraC-ATG-":[276],"complete":[282,319],"blood":[283],"results":[284,808,1019],"start":[287,348,526],"first":[290,328,383,405],"cycle":[291,329,406,993],"were:":[294],"haemoglobin":[295],"108\u00b75":[296],"(84\u2013115)":[297],"g/l,":[298],"neutrophil":[299],"count":[300,307,601],"2\u00b7835":[301],"(1\u00b701\u201310\u00b742)":[302],"\u00d7":[303,310,605,608],"109/l":[304,606],"platelet":[306,584,600,664],"88":[308],"(44\u2013138)":[309],"109/l.":[311],"Eight":[312,440],"(80%)":[314],"received":[315,679,868,938],"achieving":[318],"remission":[320],"(CR).":[321],"duration":[324],"between":[325],"78\u00b75":[333],"d":[334,369,377,509,770],"24\u2013251":[336],"d)":[337,372,380],"All":[340],"still":[343,999],"receiving":[344],"immunosuppressant(s)":[345],"AZA-GO.":[350,386,707,746],"patient":[352,357,478,545,566,598,676,694,701,710,748,1080],"course":[354,384,915,959,976],"each":[356],"shown":[359],"Fig":[361],"1.":[362],"follow-up":[365],"period":[366,954],"474":[368],"264\u2013888":[371],"323":[376],"198\u2013858":[379],"Four":[387],"(Cases":[389,397,452,482,945],"1\u20134)":[390],"eventually":[391],"relapsed.":[392],"Among":[393],"them,":[394],"three":[395,450,671,797],"1,":[398,453],"4)":[401],"relapsed":[402],"(Fig":[409,486,903,962],"1\u00b75":[418],"all":[420,517,532,575,718],"patients,":[421,672,690,842],"whereas":[422],"those":[432],"who":[434,867,1053],"did":[435,537,759],"not":[436,491,538,740,760,862,917,929,981,1117],"during":[438,540],"treatment.":[439,542,973],"had":[442,519],"discontinue":[444],"AZA-GO:":[445],"due":[446,734],"4),":[456],"infectious":[457,685,720],"episode":[458,765],"one":[460,468,474,534,544,597,675,693,700,709],"(Case":[461,469,475,546,677,695,702,749],"5),":[462],"encephalopathy":[463,752,782],"uncertain":[465,754],"aetiology":[466],"7),":[470],"non-relapse":[471],"death":[472],"9),":[476],"request":[479],"10)":[485,678],"Most":[488],"could":[490,916,928,980],"receive":[492],"because":[497,560,932],"myelosuppression":[499],"treated":[502],"interval":[506,995],"53":[508],"25\u201391":[511],"d).":[512],"With":[513,571],"regard":[514,572],"GVHD,":[516],"already":[520],"developed":[521,567,577,751,792],"GVHD":[523,536,548],"before":[524],"In":[531,543,787,856,941,1003],"but":[533,610,673],"patient,":[535],"exacerbate":[539],"10),":[547],"worsened":[549],"few":[551],"rapid":[554],"taper/discontinuation":[555],"FK":[557],"steroid":[559],"suspicion":[562],"relapse.":[564],"No":[565],"severe":[568],"chronic":[569],"GVHD.":[570],"toxicities,":[574],"grade":[578],"toxicity":[581],"required":[583],"transfusions":[585],"However,":[588,717,763,906],"toxicities":[590],"transient.":[592],"started":[595,641],"whose":[599],"below":[603],"50":[604],"(44":[607],"109/l),":[609],"platelets":[612],"recovered":[613],"pretreatment":[616],"level":[617],"2":[619],"weeks.":[620,986],"Because":[621],"early":[622],"HSCT":[625],"demonstrates":[626],"poor":[627],"outcome":[628],"(Mielcarek":[629],"2007;":[632],"Schmid":[633],"2012),":[636],"should":[639,1138],"Our":[648],"result":[649],"implies":[650],"that":[651,729,777,910,1021],"can":[653],"safely":[655],"even":[657],"relatively":[662,814],"low":[663,815],"count.":[665],"Febrile":[666],"neutropenia":[667],"(FN)":[668],"occurred":[669,687,722,766],"only":[674,956],"granulocyte":[680],"colony-stimulating":[681],"factor":[682],"support.":[683],"Seven":[684],"episodes":[686,721,731],"five":[689],"resulting":[691],"5)":[696],"discontinuing":[697],"1)":[703],"having":[704],"postpone":[706],"Furthermore,":[708,1017],"died":[711],"Pneumocystis":[713],"pneumonia":[714],"these":[719,730,778,921],"we":[727],"considered":[728],"mainly":[733],"patients'":[737],"immunosuppressive":[738],"status,":[739],"their":[742,1078],"myelosuppressive":[743],"status":[744],"One":[747],"7)":[750,948],"aetiology,":[755],"which":[757,843],"he":[758],"fully":[761],"recover.":[762],"more":[767],"than":[768,1135],"80":[769],"AZA-GO,":[772],"it":[774],"unlikely":[776],"drugs":[779],"induced":[780],"(Watanabe":[783],"2014).":[786],"our":[788,852,1018],"cohort,":[789],"no":[790,1108],"sinusoidal":[793],"obstruction":[794],"syndrome,":[795],"although":[796,861],"underwent":[799],"following":[803],"therapy.":[805,1045],"These":[806],"favourable":[807],"may":[809],"associated":[811],"dose":[816],"(3":[819],"mg/m2).":[820],"To":[821],"impact":[824],"survival":[828,831,835,1025],"rates,":[829],"overall":[830],"(OS)":[832],"disease-free":[834],"(DFS)":[836],"compared":[838,898],"control":[840,901],"(no-maintenace)":[841],"randomly":[845],"selected":[846],"database":[850],"hospital":[853],"SI).":[855],"retrospective":[858],"matched-cohort":[859],"study,":[860],"statistically":[863],"significant,":[864],"showed":[870],"higher":[871],"OS":[872],"(70\u00b70%":[873],"vs.":[877,890],"59\u00b78%":[878],"controls":[880],"1":[882,893],"year,":[883,894],"P":[884,895],"=":[885,896],"0\u00b7138)":[886],"DFS":[888],"(60\u00b70%":[889],"42\u00b78%":[891],"0\u00b7222)":[897],"S1A,":[904],"B).":[905],"some":[907],"important":[908],"factors":[909],"would":[911,1060],"affect":[912],"post-transplant":[914,972,1015,1043],"included":[919],"analyses.":[922],"For":[923],"example,":[924],"donor":[926],"source":[927],"matched":[931],"small":[934],"haploidentical":[939],"HSCT.":[940],"addition,":[942],"5":[946],"maintained":[949,968],"CR":[950,969],"long":[953],"despite":[955],"single":[958],"Such":[964],"might":[966,1023],"have":[967],"any":[971,1125],"most":[978],"Thus,":[987],"strict":[988],"indication,":[989],"optimal":[991],"matters":[1000],"discussion.":[1002],"summary,":[1004],"tolerable":[1012],"setting.":[1016],"suggest":[1020],"prolong":[1024],"AML.":[1030],"Further":[1031],"warranted":[1034],"clarify":[1036],"grateful":[1049],"participated":[1054],"study.":[1057,1090],"authors":[1059,1106],"like":[1061],"thank":[1063],"nursing":[1065],"staff":[1066],"Tokyo":[1068],"Metropolitan":[1069],"Infectious":[1072],"Diseases":[1073],"Komagome":[1075],"Hospital,":[1076],"excellent":[1079],"care.":[1081],"JA,":[1082],"TK,":[1083],"ND,":[1084],"HS,":[1085],"KO":[1087],"designed":[1088],"MS,":[1091],"KK":[1094,1099],"analysed":[1095],"data.":[1097],"GO,":[1098],"YN":[1101],"wrote":[1102],"manuscript.":[1104],"declare":[1107],"competing":[1109],"financial":[1110],"interests.":[1111],"Please":[1112],"note:":[1113],"publisher":[1115],"responsible":[1118],"content":[1121],"functionality":[1123],"supporting":[1126],"supplied":[1128],"authors.":[1131],"Any":[1132],"queries":[1133],"(other":[1134],"missing":[1136],"content)":[1137],"directed":[1140],"corresponding":[1143],"author":[1144],"article.":[1147]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}